MedPath
HSA Approval

GLYPRIN DISPERSIBLE TABLET

SIN12172P

GLYPRIN DISPERSIBLE TABLET

GLYPRIN DISPERSIBLE TABLET

January 24, 2003

DUOPHARMA (SINGAPORE) PTE LTD

DUOPHARMA (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDUOPHARMA (SINGAPORE) PTE LTD
Licence HolderDUOPHARMA (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

B01AC06

acetylsalicylic acid

Manufacturer Information

DUOPHARMA (SINGAPORE) PTE. LTD.

DUOPHARMA MANUFACTURING (BANGI) SDN.BHD.

Active Ingredients

ASPIRIN

100 mg

Aspirin

GLYCINE

45 mg

Glycine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLYPRIN DISPERSIBLE TABLET - HSA Approval | MedPath